Research Briefs: Artificial Heart Study Coverage; DNA Birth Defect Testing; Cardiac Tissue Implants
This article was originally published in The Gray Sheet
Executive Summary
SynCardia’s post-approval study of the Companion 2 driver for its Total Artificial heart will be covered under a Medicare coverage-with-evidence development policy. CARE trial finds better test for Down’s and Edward’s syndromes. Study of endogenous pulmonary valve generator begins in Russia.